CABA Earnings Date & History
Cabaletta Bio Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:16 PM ET
Cabaletta Bio Inc
Biotechnology
- Next earnings date
- Monday, November 9, 2026
- Reporting session
- Before Open
- EPS estimate
- $-0.33
- Revenue estimate
- $0
CABA earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, August 13, 2026 | Q2 2026 | $-0.38 | $-0.34 | +10.7% | $0 |
| Thursday, May 14, 2026 | Q1 2026 | $-0.41 | $-0.39 | +4.8% | $0 |
| Monday, March 23, 2026 | Q4 2025 | $-0.47 | $-0.40 | +14.9% | $0 |
| Monday, October 27, 2025 | Q3 2025 | $-0.48 | $-0.44 | +8.6% | $0 |
| Thursday, August 7, 2025 | Q2 2025 | $-0.66 | $-0.73 | -10.2% | $0 |
What the market is watching in CABA's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next CABA earnings date?
- Cabaletta Bio Inc is scheduled to report on Monday, November 9, 2026 (Before Open). Dates can change until the company confirms them.
- Does CABA report before or after the market?
- The next report is scheduled before open.
- What EPS is expected for CABA?
- Consensus EPS for the upcoming quarter is $-0.33, on revenue of $0.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
CABA earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.